A. Farrell

发表

Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms

M. Gatei, K. Khanna, M. Lavin, 1997, Oncogene.

Comparative study of radiation-induced G2 phase delay and chromatid damage in families with ataxia-telangiectasia.

M. Lavin, K. Hobson, P. Chen, 1994, Cancer genetics and cytogenetics.

Breast cancer in six women with neurofibromatosis type 1

N. Hayward, B. Teh, M. Lavin, 1997 .

Caveolin‐1‐driven membrane remodelling regulates hnRNPK‐mediated exosomal microRNA sorting in cancer

N. Cloonan, Shivangi Wani, C. Bond, 2021, Clinical and translational medicine.

Identification of a potentially radiosensitive subgroup among patients with breast cancer.

M. Walsh, M. Lavin, J. Ramsay, 1994, Journal of the National Cancer Institute.

Genetic complementation of radiation response by 3' untranslated regions (UTR) of RNA.

M. Gatei, K. Khanna, M. Buchwald, 1996, International journal of radiation biology.

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

N. Traficante, A. deFazio, J. Bedő, 2023, medRxiv.

Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction.

Jing Wang, Matt Trau, Robert A Gardiner, 2018, ACS nano.

Watters, D. et al. Cellular localization of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14, 1911-1921

M. Gatei, K. Khanna, M. Lavin, 1997 .

Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction.

K. M. Koo, H. Samaratunga, J. Yaxley, 2018, ACS nano.